Advanced Mass Spectrometry Strategies for Deciphering the Complex Composition of an Unknown Chinese Patent Medicine

Importance of the Topic

Traditional Chinese patent medicines combine herbal and animal ingredients in complex formulas that pose analytical and quality control challenges. Advanced mass spectrometry methods are essential for comprehensive profiling of bioactive components, ensuring safety, efficacy, and consistency in modern pharmaceutical applications.

Objectives and Study Overview

This study aimed to elucidate the botanical composition and active constituents of an unknown Chinese patent medicine using an integrated workflow of high-resolution LC/Q-TOF mass spectrometry, spectral databases, molecular networking, and in silico annotation tools. Key goals included targeted identification of known compounds and discovery of novel analogs.

Methodology

Sample Preparation

• Powdered sample (1.0 g) extracted in 70 percent ethanol overnight
• Ultrasonic treatment for 30 minutes, centrifugation at 15 000 rpm, supernatant collection
• Direct injection of 1 µL into LC/Q-TOF system

Acquisition Strategies

• Reverse-phase LC separation with a C18 column, gradient elution from low to high organic
• Data-independent All Ions MS/MS and data-dependent iterative MS/MS in positive and negative ion modes

Instrumentation

• Agilent 1290 Infinity II Ultra-High-Performance LC
• Agilent 6546 LC/Q-TOF mass spectrometer
• Agilent MassHunter Qualitative Analysis Software version 10.1

Main Results and Discussion

Targeted screening using the Agilent-NatureStandard TCM MS/MS library yielded 83 high-confidence identifications, revealing saponins and bile acids as primary bioactive classes. Global Natural Product Social Molecular Networking (GNPS) clustered related compounds, enabling rapid annotation of known ginsenosides and discovery of several unknown analogs such as Ginsenoside Rg1 derivatives. De novo formula assignment and structure prediction via Sirius and CSI:FingerID further identified novel Notoginsenoside R1 analogs, expanding the chemical map of the sample.

Benefits and Practical Applications

• Comprehensive quality control of complex herbal formulations
• Rapid authentication of key botanical sources and detection of adulterants
• Discovery of novel bioactive molecules for pharmacological research

Future Trends and Potential Applications

Integration with expanding spectral repositories and machine learning models will enhance automated compound annotation. Real-time mass spectrometry screening and miniaturized portable instruments could enable point-of-care verification of herbal products. Synthetic biology approaches may leverage newly identified compounds for drug development.

Conclusion

The combined use of Agilent PCDL libraries, GNPS molecular networking, and Sirius in silico tools offers a powerful strategy to decipher complex Chinese patent medicines, enabling both targeted and untargeted identification of bioactive constituents and novel analogs.

References

• ASMS 2025 Poster MP 219 by Shuna Fu and Huakai Wu
• Agilent Technologies Application Note DE-006632, published May 15 2025